Cycle Pharmaceuticals Ltd.: Clinical Trials

6 trials sponsored by Cycle Pharmaceuticals Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow Cycle Pharmaceuticals Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fed Conditions
Haloperidol Tablets, Mylan Pharmaceuticals Inc., Haloperidol Tablets, Cycle Pharmaceuticals Ltd - Bioequivalence
Phase 1CompletedCycle Pharmaceuticals Ltd.322019-11-152022-06-08
Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions
Haloperidol Tablets, Mylan Pharmaceuticals Inc., Haloperidol Tablets, Cycle Pharmaceuticals Ltd - Bioequivalence
Phase 1CompletedCycle Pharmaceuticals Ltd.322019-11-152022-06-08
Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
Chlorpromazine Hydrochloride - Anti-Psychotic, Management of Manifestations of Psychotic Disorders
Phase 1CompletedCycle Pharmaceuticals Ltd.202016-11-012017-11-14
Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)
Nitisinone, Nitisinone Baked Tablet, Orfadin - Hereditary Tyrosinemia, Type I
Phase 1CompletedCycle Pharmaceuticals Ltd.242016-03-012017-06-14
Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)
Nitisinone - Hereditary Tyrosinemia, Type I
Phase 1CompletedCycle Pharmaceuticals Ltd.202015-11-012017-03-15
Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin
Nitisinone, Nitisinone 10 mg Tablet High Compritol, Orfadin - Hereditary Tyrosinemia, Type I
Phase 1CompletedCycle Pharmaceuticals Ltd.242015-10-012017-03-15

Conditions studied

Tyrosinemias (3)  ·  Porphyria, Acute Intermittent (1)  ·  Vomiting (1)

Interventions

nitisinone (3)  ·  Benztropine (2)  ·  Chlorpromazine (1)  ·  Tablets (1)

Countries

South Africa (6)

Top investigators

Dr. Yolandi Swart, FCPHM(SA) (1)